Characterized by compulsive drinking, loss of control, and negative emotional states when not using, alcohol use disorder (AUD) was recently linked to dementia. Despite advances in neuroscience and genetics, relapses approach 60-70 percent within a year of treatment cessation. Medications like naltrexone, acamprosate, and disulfiram were FDA-approved decades ago, and demonstrate consistent benefits—yet are rarely utilized.
Mark S. Gold, M.D., is a pioneering researcher, professor, and chairman of psychiatry at Yale, the University of Florida, and Washington University in St Louis. His theories have changed the field, stimulated additional research, and led to new understanding and treatments for opioid use disorders, cocaine use disorders, overeating, smoking, and depression.
Read full article
